Clinical trial
Neurologic Bone Marrow Derived Stem Cell Treatment Study
NCT02795052 is registered in ClinicalTrials.gov with MD Stem Cells as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurologic Bone Marrow Derived Stem Cell Treatment Study
- Lead sponsor
- MD Stem Cells
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 30, 2016
- Completion date
- July 31, 2028
- Enrollment
- 500 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
als, alzheimer disease, amyotrophic lateral sclerosis, cadasil, cerebral hemorrhage, cerebral infarction, cerebral ischemia, cerebral stroke, chronic traumatic encephalopathy, cognitive impairment, dementia, diabetic neuropathies, frontotemporal dementia, lewy body disease, lewy body variant of alzheimer disease, msa - multiple system atrophy, multi-system degeneration, nervous system diseases, neurodegenerative diseases, neurologic disorders, neurological disorders, neuropathy, parkinson, progressive supranuclear palsy, stroke, traumatic brain injury